Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22295 | 330 | 49.9 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1650 | 6377 | BICLUSTERING//PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PROGRAM TRANSLAT IMMUNOVIROL BIODEF | Address | 34 | 46% | 17% | 56 |
| 2 | MAYO VACCINE GRP | Address | 27 | 38% | 17% | 57 |
| 3 | MAYO CLIN VACCINE GRP | Address | 12 | 59% | 4% | 13 |
| 4 | PROGRAM TRANSLAT IMMUNOVIROL BIODEFENSE | Address | 9 | 55% | 4% | 12 |
| 5 | SYSTEMS VACCINOLOGY | Author keyword | 8 | 62% | 2% | 8 |
| 6 | VACCINE GRP | Address | 7 | 26% | 7% | 23 |
| 7 | MOL BIOL VIRAL ONCOGENESIS | Address | 3 | 39% | 2% | 7 |
| 8 | TRANS NIH HUMAN IMMUNOL AUTOIMMUN INFLAMMAT | Address | 3 | 100% | 1% | 3 |
| 9 | RUBELLA VACCINE | Author keyword | 3 | 21% | 3% | 11 |
| 10 | SYST GENOM BIOINFORMAT UNIT | Address | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SYSTEMS VACCINOLOGY | 8 | 62% | 2% | 8 | Search SYSTEMS+VACCINOLOGY | Search SYSTEMS+VACCINOLOGY |
| 2 | RUBELLA VACCINE | 3 | 21% | 3% | 11 | Search RUBELLA+VACCINE | Search RUBELLA+VACCINE |
| 3 | VACCINOMICS | 2 | 31% | 2% | 5 | Search VACCINOMICS | Search VACCINOMICS |
| 4 | MEASLES PEPTIDES | 1 | 100% | 1% | 2 | Search MEASLES+PEPTIDES | Search MEASLES+PEPTIDES |
| 5 | MEASLES VACCINE IMMUNITY | 1 | 100% | 1% | 2 | Search MEASLES+VACCINE+IMMUNITY | Search MEASLES+VACCINE+IMMUNITY |
| 6 | MEASLES VIRUS RECEPTORS | 1 | 50% | 1% | 2 | Search MEASLES+VIRUS+RECEPTORS | Search MEASLES+VIRUS+RECEPTORS |
| 7 | SYSTEMS IMMUNOLOGY | 1 | 23% | 2% | 5 | Search SYSTEMS+IMMUNOLOGY | Search SYSTEMS+IMMUNOLOGY |
| 8 | HLA DRB103 | 1 | 40% | 1% | 2 | Search HLA+DRB103 | Search HLA+DRB103 |
| 9 | VACCINE RESPONSE | 1 | 13% | 2% | 6 | Search VACCINE+RESPONSE | Search VACCINE+RESPONSE |
| 10 | DECONVOLUTION APPROACH | 1 | 50% | 0% | 1 | Search DECONVOLUTION+APPROACH | Search DECONVOLUTION+APPROACH |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | YELLOW FEVER VACCINE | 12 | 22% | 15% | 48 |
| 2 | MEASLES VACCINE | 7 | 21% | 9% | 30 |
| 3 | CLADE A | 4 | 38% | 2% | 8 |
| 4 | HIV 1 ISOLATE | 3 | 60% | 1% | 3 |
| 5 | MUMPS RUBELLA VACCINE | 3 | 19% | 4% | 12 |
| 6 | CYTOKINE RECEPTOR GENES | 2 | 67% | 1% | 2 |
| 7 | SYSTEMS VACCINOLOGY | 1 | 31% | 1% | 4 |
| 8 | IL18 GENES | 1 | 100% | 1% | 2 |
| 9 | MEASLES VIRUS RECEPTORS | 1 | 50% | 1% | 2 |
| 10 | EMERGING FIELD | 1 | 16% | 2% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses | 2014 | 10 | 50 | 42% |
| Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates | 2012 | 8 | 17 | 65% |
| The genetic regulation of infant immune responses to vaccination | 2015 | 2 | 47 | 47% |
| Searching for the human genetic factors standing in the way of universally effective vaccines | 2015 | 2 | 88 | 33% |
| The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches | 2013 | 13 | 100 | 37% |
| Detecting specific infections in children through host responses: a paradigm shift | 2014 | 5 | 42 | 38% |
| Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development | 2011 | 13 | 54 | 54% |
| Immunogenomics approaches for vaccine evaluation | 2012 | 2 | 20 | 55% |
| Vaccinology in the era of high-throughput biology | 2015 | 1 | 69 | 33% |
| Interindividual variations in the efficacy and toxicity of vaccines | 2010 | 17 | 56 | 34% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROGRAM TRANSLAT IMMUNOVIROL BIODEF | 34 | 46% | 17% | 56 |
| 2 | MAYO VACCINE GRP | 27 | 38% | 17% | 57 |
| 3 | MAYO CLIN VACCINE GRP | 12 | 59% | 3.9% | 13 |
| 4 | PROGRAM TRANSLAT IMMUNOVIROL BIODEFENSE | 9 | 55% | 3.6% | 12 |
| 5 | VACCINE GRP | 7 | 26% | 7.0% | 23 |
| 6 | MOL BIOL VIRAL ONCOGENESIS | 3 | 39% | 2.1% | 7 |
| 7 | TRANS NIH HUMAN IMMUNOL AUTOIMMUN INFLAMMAT | 3 | 100% | 0.9% | 3 |
| 8 | SYST GENOM BIOINFORMAT UNIT | 2 | 67% | 0.6% | 2 |
| 9 | VIRAL ONCOGENESIS IMMUNOTHER IES | 1 | 100% | 0.6% | 2 |
| 10 | CAMBRIDGE METAB S | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000179390 | RTF//ESTADD//ESTOUT |
| 2 | 0.0000110880 | MERIEUX//BLOOD TRANSCRIPTOME//DUTCH NUTRIGENOM CONSORTIUM |
| 3 | 0.0000105246 | MEASLES VIRUS//SSPE VIRUS//VIROL IMMUNOBIOL |
| 4 | 0.0000090471 | MEASLES//MEASLES VACCINE//MEASLES ELIMINATION |
| 5 | 0.0000088132 | YELLOW FEVER//YELLOW FEVER VACCINE//YELLOW FEVER VIRUS |
| 6 | 0.0000076658 | INFLUENZACHINESE INFLUENZA//IMMUNOL PATHOGENESIS BRANCH//INT INFECT IMMUN |
| 7 | 0.0000075930 | IMMUNOINFORMATICS//EPITOPE PREDICTION//COMPUTATIONAL VACCINOLOGY |
| 8 | 0.0000075644 | COMMUNITY PEDIAT ADOLESCENT MED//IMMUNE INCOMPETENCE//ROCHESTER EPIDEMIOLOGY PROJECT |
| 9 | 0.0000070335 | IMGT//UPR CNRS 1142//CNRSUPR 1142 |
| 10 | 0.0000057568 | CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS//RUBELLA |